During the past decade, Hospital da Restauração conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital da Restauração" #1 collaborator was "Bayer" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital da Restauração" are "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Pseudobulbar Affect (PBA)" (1 trials). Many other conditions were trialed in "Hospital da Restauração" in a lesser frequency.

Most popular intervention types in "Hospital da Restauração" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alemtuzumab 12 mg" (1 trials), "Alemtuzumab 24 mg" (1 trials), "Interferon beta-1a" (1 trials), "Placebo" (1 trials) and "dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital da Restauração" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hospital da Restauração". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hospital da Restauração, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital da Restauração, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".